#Truvada

She trains similar women living with HIV to become Justice Advocates!

Researchers believe that hepatitis C is spreading through sex from the HIV-positive population to those who don’t have HIV.

Informal PrEP users were more likely to take it intermittently and skip recommended medical tests.

Pharma sets the prices for HIV and hep C drugs very high. What happens to those prices along the supply chain?

The day after CDC Director Robert Redfield was confronted at AIDSWatch, hill visits by advocates produced “strong interest” in hearings.

The new federal plan to combat HIV has the audacious goal of cutting the annual infection rate by 90 percent by 2030.

The CDC holds the patents to Truvada-as-PrEP, but hasn’t asked for a dime in royalties from Gilead. This is costing taxpayers billions. Why?

We take a look at the first-ever release of comprehensive region-level PrEP use data in New York.

This cheap test could be a good way to assess adherence, unless those who adhere poorly fudge the result by taking a dose before a visit.

The Conference on Retroviruses and Opportunistic Infections in Seattle saw many important studies that are advancing the fight against HIV.

A study of young gay and bi men and trans women in Chicago found PrEP stigma was linked with lower rates of use of Truvada for prevention.

Waiting for all lab tests to return before prescribing Truvada resulted in a high dropout rate among those visiting sexual health clinics.

A third of at-risk gay and bi men are now using Truvada for HIV prevention, the CDC says.

People with commercial insurance stayed on PrEP about twice as long as those covered by Medicaid.

This held true even among those with resistance to nucleoside/nucleotide reverse transcriptase inhibitors.

Plus: Once again federal funds get diverted from health care and into the detention of immigrant youth.